Extrapolation of indications in biosimilars: filgrastim

posted 21/11/2014

Extrapolation* of indications for biosimilars is a contentious issue and has been met with concern by physicians. Members of the European Medicines Agency (E...

more
More discussion over WHO biological qualifier Biosimilars/General | Posted 21/11/2014
Chinese guidelines for biosimilars Guidelines | Posted 21/11/2014
EMA criticized for redaction of AbbVie’s data Policies & Legislation | Posted 21/11/2014
Amgen launches biosimilars info app Biosimilars/News | Posted 21/11/2014
Investigation into huge price increases for gen... Generics/General | Posted 21/11/2014
Cipla petitions Indian Government to revoke Onb... Generics/News | Posted 21/11/2014
China releases draft biosimilars guidance Guidelines | Posted 14/11/2014
Biosimilars: when indications can be extrapolated Biosimilars/Research | Posted 14/11/2014
Amgen sues Sandoz over filgrastim biosimilar Biosimilars/News | Posted 14/11/2014
Canada partially lifts import ban on Indian man... Generics/General | Posted 14/11/2014
Biosimilars use in Europe varies widely Reports | Posted 14/11/2014
Another old drug to see huge price increase in US Policies & Legislation | Posted 14/11/2014
Biosimilars: similar but not identical Biosimilars/Research | Posted 07/11/2014
Predicting the response of diabetes patients to... Biosimilars/Research | Posted 07/11/2014
India’s policies prevent secondary patenting an... Policies & Legislation | Posted 07/11/2014
Study into switching from Aranesp to biosimilar... Biosimilars/News | Posted 07/11/2014
Coherus sells shares to raise funds for biosimi... Biosimilars/News | Posted 07/11/2014
Improved labelling sought for biosimilar accept... Biosimilars/Research | Posted 31/10/2014
Patients satisfied with generics Reports | Posted 31/10/2014
Biosimilars of pegfilgrastim Biosimilars/General | Posted 31/10/2014
Mylan latest to recall blood pressure generics Generics/News | Posted 31/10/2014
LG Life Sciences and Mochida make deal for adal... Biosimilars/News | Posted 31/10/2014
Study results show safety of switching to biosi... Biosimilars/Research | Posted 31/10/2014
Endo accused of Opana pay-for-delay Policies & Legislation | Posted 31/10/2014
Supernus sues Actavis over generic Trokendi XR Pharma News | Posted 31/10/2014
Extrapolation for biosimilars Biosimilars/Research | Posted 24/10/2014
Biosimilar bevacizumab similar to Avastin in pr... Biosimilars/Research | Posted 24/10/2014
Changes to pharmaceutical policy during an econ... Generics/Research | Posted 24/10/2014
Norwegian study may be slowing adoption of bios... Biosimilars/News | Posted 24/10/2014
FDA names and shames firms for failing to pay g... Generics/General | Posted 24/10/2014
Generics firms carve their way to victory Generics/News | Posted 24/10/2014
India drops planned price caps on non-essential... Policies & Legislation | Posted 24/10/2014
Mobilization of stem cells by biosimilar Nivest... Biosimilars/Research | Posted 17/10/2014
Reference pricing and generics in Finland Generics/Research | Posted 17/10/2014
Stada in-licenses teriparatide biosimilar Biosimilars/News | Posted 17/10/2014
French generics association promotes biosimilars Conferences | Posted 17/10/2014
Canada bans imports from three API facilities i... Generics/General | Posted 17/10/2014
Implications of Canadian–European Trade Agreeme... Policies & Legislation | Posted 17/10/2014
Phase III study of biosimilar adalimumab meets... Biosimilars/Research | Posted 10/10/2014
Generics in Taiwan: urban–rural disparity Generics/Research | Posted 10/10/2014
more

Generics News Research General

more

Biosimilars News Research General

more